Global beauty and health care company SD Biotechnologies is seeking to appeal to global millennial consumers with newly launched SNP mini and SNP prep skincare products, the company said Thursday. SNP mini is a pouch-type skincare set, comprising six items -- cleansing foam, toner, facial essence, serum, eye and facial nourishing cream and tone-up cream. SNP prep is a large-size product line copious enough to apply for both the face and body. The series’ Peptaronic set, a combination of pe

Telecom firm KT said Thursday it will provide an optimal emergency rescue protocol using 5G and artificial intelligence technology by collaborating with the National Fire Agency and Severance Hospital. The triumvirate is jointly devising a new smart emergency response service that embeds 5G network for medical emergencies from the 119 emergency call reception to ambulance transportation and hospital emergency room care. As the first step, KT and the NFA on Thursday launched a 5G-based 119 video

Prosecutorial reform was the hottest trending topic on Twitter in Korea this year, according to data released by the social media platform on Tuesday. It was the most mentioned social keyword on Twitter in Korea between Jan. 1 and Nov. 15. The “boycott Japan” movement followed in second place with over 1.3 million mentions in the cited period.Former Justice Minister Cho Kuk, who resigned after submitting his proposal for prosecutorial reform, was the most-mentioned person of the year

Samyang Biopharm USA has licensed in Belgium’s Talix Therapeutics’ first-in-class immuno-oncology compound for global rights, the companies said Tuesday. Financial details of the agreement were not disclosed.Under the agreement, Samyang Biopharmaceuticals’ subsidiary will gain the research rights, as well as exclusive options to worldwide rights for development, manufacturing and commercialization of Talix’s anti-CD96 antibody.The anti-CD96 antibody is a first-in-class co

Amid the recent controversy over unfair contracts of young professional esports players in South Korea, the Fair Trade Commission on Monday pledged to comb through the relevant regulations and examine all contracts.Currently, the watchdog is undertaking preliminary inspections of Korea e-Sports Association’s standard contract and a full-fledged review of major esports teams will begin as soon as possible, a FTC official confirmed to The Korea Herald.Any unfair clauses found during the inve

Telecom KT’s disease control platform recently launched in Kenya, widening reach in the African continent.KT’s Global Epidemic Prevention Platform will be locally serviced by the nation’s biggest telecom provider Safaricom, and will be called Safari Smart, meaning “smart travel” in Swahili. KT underlined the significance of this collaboration, saying this is the first time for a Korean company to tap Kenya’s national quarantine service. Kenya is a critical hub

Hanwha Systems announced Sunday that its $25 million investment in US-based air taxi startup Overair has got final approval from authorities.The two companies plan to jointly develop personalized aerial vehicles following the US Committee on Foreign Investment’s greenlight. Overair, previously K4 Aeronautics, is a spinoff of Karem Aircraft -- which manufactures aerial vehicles capable of vertical takeoff and landing. It is one of the core partners of the Uber Elevate project for commercial

Cha University’s Region-Specific Resource Advancement Center in Northeast Region of Gyeonggi-do (GRRC) recently held a symposium to present cutting-edge technology on natural resources’ separation and refinement using Prep-HPLC technology, it said Thursday. GRRC is a regional platform to share the latest expert scientific opinions on participating corporations’ local natural resources-based novel drug development.  The event held on Sept. 27 marked the sharing of technolog

Ballantine’s was the most consumed Scotch whiskey in Korea in the last three years with a market share of 28 percent, its distributor Pernod Ricard Korea said Thursday. “Data shows the international Scotch whiskey market in Korea grew by an average 7 percent every year since 2017,” said Florent Leroi, chief of Pernod Ricard Korea’s marketing division. “During this period, Ballantine’s revenue grew by an annual average of 9.2 percent,” Leroi said, un

A new contract manufacturing deal bagged by Samsung BioLogics, potentially worth 86 billion won ($72 million), has boosted its target stock price. SK Securities on Wednesday adjusted its target price for Samsung BioLogics shares to 470,000 won, from the previous 400,000 won. “Samsung BioLogics’ 2020 unconsolidated operating profit is anticipated to increase 684.5 percent on-year to 234 billion won,” said analyst Lee Dal-mi, along with forecasting that its 2019 operating profit

Israeli company Alma Lasers, a leading player in China’s skin rejuvenation market, is undertaking an aggressive expansion into South Korea, viewing the country as a strategic market for its brand image. “Korea is a very important market. Being here is not only for revenue -- this is a market that we believe is a bridge to other markets in Asia,” said Lior Dayan, CEO of Sisram Medical, Alma’s parent company, in a conference call interview with The Korea Herald. “When

Nexon’s V4 and Zabob Studio’s Coin Princess won November’s G-Rank Game of the Month and Challenge Seoul award, respectively, the company said Friday.The G-Rank awards ceremony took place at OGN E-sports Stadium in Sangam-dong, Seoul, Thursday. November’s game, V4, is a mobile MMORPG made using Unreal Engine 4. It boasts high-end graphics, a vast virtual combat field and character customizing features that reportedly won many fans. Challenge Seoul award winner Coin Princes

Kakao’s Klaytn has ambitions to become the world’s biggest public blockchain consortium, said Kakao CEO Yeo Min-soo, Thursday, at the first Klaytn Governance Council Summit held in Seoul.“Currently, Klaytn’s expansion is centered in Asia, but it will gradually spread, in the end becoming the best global blockchain platform. To that end, we will not spare any investment and implore the Governance Council members to actively join in on the growth of our ecosystem,” sa

진행자: 임정요, Kevin Lee Selzer1. Korea, ASEAN adopt joint vision for cooperation기사 요약: 부산에서 열린 한아세안 특별 정상회담에서 참가국들 자유무역을 약속했다.아이튠즈(아이폰): https://itunes.apple.com/kr/podcast/koliaheleoldeu-paskaeseuteu/id686406253?mt=2팟빵 (안드로이드): http://www.podbbang.com/ch/6638[1] BUSAN – The ASEAN-ROK Commemorative Summit wrapped up Tuesday with the leaders agreeing to expand economic, political and social cooperation among the countries. *wrap up: 끝마치다*expand: 확장하다[2] “Advancement of the ASEAN is Korea&

South Korea’s NCSoft launched Lineage2M, mobile version of the massively multiplayer online role-playing PC game Lineage 2, at midnight Tuesday. The MMORPG is the game company’s first new title in two years that is hoped to boost its annual revenue past the 2 trillion won ($1.7 billion) mark to join its competitors Nexon and Netmarble.Prior to the launch, Lineage2M topped the popularity list on both Google Play and App Store. Advance sign-ups for the game notched 7.38 million, a reco

SK Biopharmaceuticals has a full value chain ready for its newly approved partial onset seizure epilepsy drug Xcopri, said the company’s CEO Cho Jeong-woo, Tuesday. Beginning from compound discovery to preclinical trials, clinical trials and product approval in the US, SK Biopharmaceuticals has directly overseen every step of Xcopri’s commercialization. Now it will continue to directly handle local marketing and sales from the second quarter of 2020, said Cho during a press conferenc

Celltrion said Tuesday its infliximab biobetter Remsima SC has received the European Medicines Agency’s approval for sales in the continent. Remsima SC’s main target patients are those who are resistant to original TNF-a inhibitors such as Humira (adalimumab) and Enbrel (etanercept).  While infliximab currently takes up only 9 percent of the rheumatoid arthritis treatment market, the rate of patients who are prescribed a different medication -- apart from adalimumab and etanerce

When 93-year-old Korean pharmaceutical firm Yuhan signed a collaboration deal with Johnson & Johnson’s subsidiary Janssen a year ago, it excited bio investors here and abroad. The transaction, reaching up to 1.4 trillion won ($1.19 billion), was the second biggest in the history of Korean biopharma research and development at the time. Janssen was interested in Yuhan’s lazertinib pipeline for third-generation lung cancer. Since then, Gilead signed a deal worth 878 billion won to

Biotech startup Bridge Biotherapeutics is on its way to becoming the first Kosdaq-listed no-research, development-only company in Korea by the end of this year, the company said Friday.This is the company’s third attempt at making an initial public offering, and more promising than the previous two attempts on the back of the record 1.5 trillion-won ($1.27 billion) licensing out to Germany’s Boehringer Ingelheim in July. In a press conference held at Conrad Seoul, CEO Lee Jung-kue sa

A new South Korean anti-epileptic drug will be available in the US from as early as April. The US’ Food and Drug Administration has approved SK Biopharmaceuticals’ anti-epileptic drug XCOPRI (Cenobamate), officials said Friday. The product will be available in the second quarter of 2020 after review by the US Drug Enforcement Administration.The marketing and sales process will be overseen by SK Life Science, the US subsidiary of SK BIopharmaceuticals based in Paramus, New Jersey. XCO